Gary Visit 1: An elderly male presenting with worsening COPD symptoms

Title:

Gary Visit 1: An elderly male presenting with worsening COPD symptoms

Topic: Pulmonary Disease
Relevant Terms: Aerosol Devices, Chronic Obstructive Pulmonary Disease (COPD)
Primary Audience: This activity has been designed to meet the educational needs of Pulmonologists; Primary Care Physicians; Registered Nurses; and other healthcare professionals (HCPs) who are interested in the care of patients with COPD.
Launch Date: 11-Dec-12
Credits: 0.75 AMA PRA Category 1 Credit
0.7 ANCC contact hour
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Improving the Management of COPD: Choosing the Right Device for Maintenance Therapy

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Discuss the recent updates to COPD management in the GOLD recommendations
  2. Discuss the appropriate use of short-acting and long-acting bronchodilators in the treatment of COPD
  3. Review tools used to monitor COPD progression and development of complications
  4. Increase awareness, knowledge, and confidence in selecting an appropriate aerosol device for patients who have physical or mental comorbidities as well as others who are difficult to manage
  5. Provide appropriate care and counsel for patients and their families 

    Faculty

    Richard A. Goldstein, MD
    Senior Attending Physician, Dept. of Medicine
    Raritan Bay Medical Center
    Perth Amboy, New Jersey
    Stanley B. Fiel, MD
    Professor of Medicine
    Mt. Sinai School of Medicine
    Chairman of Medicine
    Morristown Medical Center
    Morristown, New Jersey
    Program Overview
    COPD represents an important global public health challenge that is both preventable and treatable. However, many COPD sufferers are undiagnosed, underdiagnosed, and/or undertreated. The disease is the third leading cause of death in the United States, affecting as many as 24 million Americans and resulting in 1.5 million ED visits, 700,000 hospital admissions, and 124,000 deaths annually. Because COPD is a complex disease with heterogeneity present at many levels (across pathways, phenotypes, and patients), the mechanisms underlying the disease hold the key to future therapeutic approaches. Currently, the daily challenges for HCPs treating and managing patients with COPD involve the practical clinical identification and interpretation of readily available markers of disease severity and progression and the appropriate selection of maintenance therapy that addresses the severity, slows the progression, and provides individualized therapy for patients who also may have age-related comorbidities and other physical and mental deficiencies. Thus, this learning initiative will provide HCPs with practical clinical advice on how to manage COPD in their practice to achieve a better quality of life for their patients.                                               
     

    Program Agenda
    45 minutes
     
    Method of Participation
    Online

    Media
    Internet
     
    Course Viewing Requirements
    Google Chrome for Windows, Mac, or Linux
    Internet Explorer 7.0+ for Windows
    Mozilla 1.4+ for Windows, Mac, or Linux
    Firefox 3.5+ for Windows, Mac, or Linux
    Safari 4.0+ for Mac

    Physician Continuing Medical Education
    Accreditation Statement
    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and Educational Concepts in Medicine. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians. 

    Credit Designation
    The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Nursing Continuing Education
    Accreditation Statement
    Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. 

    Credit Designation
    This educational activity for
     0.70 ANCC contact hours is provided by Postgraduate Institute for Medicine



    (www.pimed.com)



    How to Receive Credit
    By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive a maximum of 0.75 AMA PRA Category 0.75 Credit(s)™ and registered nurses are entitled to 0.7 ANCC contact hours. A statement of credit will be available to print from your user history page.
     
    • Read the learning objectives and faculty disclosures.
    • Participate in the activity.
    • Complete the post-test and activity evaluation.
    • Physicians who successfully complete the post-test and evaluation will receive CME credit. You must score with a 70% or higher on the post-test to receive credit for this activity.
    • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.

    Disclosure of Conflicts of Interest
    Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PIM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

    The 
    faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: 


    Name of Faculty Presenter and Planning Committee
    Reported Financial Relationship
    Stanley B. Fiel, MD
    Has served as a consultant/speaker on the advisory boards of Mylan, Merck, GiLead, and Novartis.
    Rich Goldstein, MD
    Has served as a consultant on the advisory board of Mylan. 
     
    The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:


    Name of Planner or Manager
    Reported Financial Relationship
    PIM Clinical Reviewers: Laura Excell, ND, NP, MS, MA, LPC, NCC; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CCMEP; Jan Schultz, RN, MSN, CCMEP; and Patricia Staples, MSN, NP-C, CCRN
    Have no real or apparent conflicts of interest to report.
    ECM: Patrick J. Crowley, MBA, Managing Director; Jodi Andrews, BS, Director, Educational Programs; Christie Brid, Program Coordinator; Lilly Ostrovsky, MS, Editorial Services
    Have no real or apparent conflicts of interest to report.


    Disclosure of Unlabeled Use
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM), Educational Concepts in Medicine (ECM), and Mylan Pharmaceuticals do not recommend the use of any agent outside of the labeled indications. 

    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, ECM, and Mylan Pharmaceuticals. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


    Disclaimer
    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. 
     
    Fee Information
    There is no fee for this educational activity.

    Commercial Support
    This activity is supported by an educational grant from Mylan, Inc.